By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Abbott today reported that its fourth-quarter molecular diagnostics sales increased 21 percent year over year.

Abbott's total diagnostics sales were $1.02 billion for the quarter, up 4 percent year over year.

Its molecular diagnostics sales contributed $114 million to that total and were up 21 percent. Its US molecular diagnostics sales were $55 million, up 32 percent, and its international sales were up roughly 13 percent at $59 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.